NCT00488813

Study of Antibiotic Utilization Measures and Control of ESBLs in China

Association of Antibiotic Utilization Measures and Control of Extended-spectrum β-lactamases (ESBLs) in MICU1 and MICU2 at Buddhist Tzu Chi General Hospital.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 300 (planned)
• Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A single-center, prospective, comparative, antibiotic intervention study for patients admitted to MICU1 and MICU2

Detailed description

1. To determine the value of using β-lactamases inhibitors in reducing the cases of ESBL producing E. coli or K. pneumoniae colonization and infection after 12 months. 2. To compare the acquisition rates of ESBL producing E. coli or K. pneumoniae at MICU1 and MICU2 after 12 months

Conditions

• ICU Patient

Interventions

Type	Name	Description
DRUG	Third generation cephalosporins

Timeline

• Start date: 2004-07-01
• Primary completion: 2005-06-01
• Completion: 2005-06-01
• First posted: 2007-06-20
• Last updated: 2009-09-09